Company / EPS (Basic)
TherapeuticsMD, Inc. EPS (Basic) History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$0.99
FY2024
5-year range
-$21.66 / $12.41
FY2022-FY2024
Trend
-108.0%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-21.66 to $-0.99 over the past 2 years.
Based on SEC 10-K filings.
-0.99 in FY2024.
Improved from $-21.66 to $-0.99 over the past 2 years.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, eps (basic) decreased 108.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$0.99 | -108.0% |
| FY2023 | $12.41 | +157.3% |
| FY2022 | -$21.66 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026